USNA Stock Overview
Develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
USANA Health Sciences, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$48.99 |
| 52 Week High | US$69.60 |
| 52 Week Low | US$41.45 |
| Beta | 0.94 |
| 1 Month Change | 11.01% |
| 3 Month Change | -0.83% |
| 1 Year Change | -23.79% |
| 3 Year Change | -51.97% |
| 5 Year Change | -33.73% |
| Change since IPO | 7,939.38% |
Recent News & Updates
USANA Health Sciences, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
May 03
Is Now The Time To Look At Buying USANA Health Sciences, Inc. (NYSE:USNA)?
May 01Recent updates
USANA Health Sciences, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
May 03Is Now The Time To Look At Buying USANA Health Sciences, Inc. (NYSE:USNA)?
May 01USANA Health Sciences, Inc.'s (NYSE:USNA) Prospects Need A Boost To Lift Shares
Apr 04USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital
Feb 08Is It Too Late To Consider Buying USANA Health Sciences, Inc. (NYSE:USNA)?
Jan 06USANA: New Digital Tools And Solid Balance Sheet Imply Undervaluation
Oct 23Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 22%?
Sep 09Here's What's Concerning About USANA Health Sciences' (NYSE:USNA) Returns On Capital
Jul 27USANA Earnings Preview: From China's Challenge To India's Promise
Jul 21USANA Health Sciences says Brown will transition to CEO in July 2023
Feb 13Returns On Capital At USANA Health Sciences (NYSE:USNA) Paint A Concerning Picture
Feb 02USANA Health Sciences down 17% after revising 2022 outlook below consensus estimates
Oct 25Here's What To Make Of USANA Health Sciences' (NYSE:USNA) Decelerating Rates Of Return
Oct 18Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 26%?
Jul 22Returns On Capital At USANA Health Sciences (NYSE:USNA) Have Stalled
Jul 07Is USANA Health Sciences (NYSE:USNA) Using Too Much Debt?
Jun 14Is USANA Health Sciences, Inc. (NYSE:USNA) Potentially Undervalued?
May 31USANA: Soft Quarter, Bottomed Out Stock, 9.8x Ex-Cash P/E, 65% Upside
Apr 28Capital Investments At USANA Health Sciences (NYSE:USNA) Point To A Promising Future
Mar 05USANA: 15x P/E, 14% Net Cash, Stock Repurchases
Feb 17A Look At The Intrinsic Value Of USANA Health Sciences, Inc. (NYSE:USNA)
Jan 24At US$99.77, Is It Time To Put USANA Health Sciences, Inc. (NYSE:USNA) On Your Watch List?
Jan 11Shareholder Returns
| USNA | US Personal Products | US Market | |
|---|---|---|---|
| 7D | 4.9% | 0.5% | 1.7% |
| 1Y | -23.8% | -22.7% | 26.3% |
Return vs Industry: USNA underperformed the US Personal Products industry which returned -22.7% over the past year.
Return vs Market: USNA underperformed the US Market which returned 26.3% over the past year.
Price Volatility
| USNA volatility | |
|---|---|
| USNA Average Weekly Movement | 4.6% |
| Personal Products Industry Average Movement | 8.6% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in US Market | 16.0% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: USNA has not had significant price volatility in the past 3 months.
Volatility Over Time: USNA's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 1,800 | Jim Brown | www.usana.com |
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups.
USANA Health Sciences, Inc. Fundamentals Summary
| USNA fundamental statistics | |
|---|---|
| Market cap | US$933.29m |
| Earnings (TTM) | US$61.94m |
| Revenue (TTM) | US$900.45m |
15.1x
P/E Ratio1.0x
P/S RatioIs USNA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| USNA income statement (TTM) | |
|---|---|
| Revenue | US$900.45m |
| Cost of Revenue | US$171.24m |
| Gross Profit | US$729.21m |
| Other Expenses | US$667.27m |
| Earnings | US$61.94m |
Last Reported Earnings
Mar 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.25 |
| Gross Margin | 80.98% |
| Net Profit Margin | 6.88% |
| Debt/Equity Ratio | 0.3% |
How did USNA perform over the long term?
See historical performance and comparison